Organigram (TSE:OGI) PT Lowered to C$1.30

Organigram (TSE:OGI – Get Rating) had its price target dropped by Alliance Global Partners from C$1.50 to C$1.30 in a report released on Friday, BayStreet.CA reports. Alliance Global Partners’ target price indicates a potential downside of 2.26% from the stock’s previous close. Alliance Global Partners also issued estimates for Organigram’s FY2025 earnings at ($0.06) EPS.

OGI has been the subject of a number of other research reports. Jefferies Financial Group reduced their price objective on Organigram from C$2.60 to C$2.00 in a research report on Friday, December 23rd. Stifel Nicolaus raised Organigram from a “hold” rating to a “buy” rating in a report on Friday. Two research analysts have rated the stock with a hold rating and four have issued a buy rating to the company. Based on data from MarketBeat, the company currently has a consensus rating of “Moderate Buy” and a consensus target price of C$2.06.

Organigram Stock Up 10.8 %

Shares of TSE:OGI opened at C$1.33 on Friday. Organigram has a 52-week low of C$0.96 and a 52-week high of C$2.32. The firm has a market capitalization of C$417.43 million and a P/E ratio of -11.27. The stock has a 50 day moving average price of C$1.25 and a 200-day moving average price of C$1.30. The company has a debt-to-equity ratio of 0.66, a quick ratio of 2.62 and a current ratio of 4.01.

Organigram (TSE:OGI – Get Rating) last posted its quarterly earnings data on Monday, November 28th. The company reported C($0.02) earnings per share for the quarter, meeting analysts’ consensus estimates of C($0.02). The company had revenue of C$45.48 million for the quarter, compared to the consensus estimate of C$43.15 million. As a group, equities research analysts anticipate that Organigram will post -0.12 EPS for the current fiscal year.

Organigram Company Profile

(Get Rating)

Organigram Holdings Inc, through its subsidiaries, engages in the production and sale of cannabis and cannabis-derived products in Canada. It offers medical cannabis products, including cannabis flowers, gummies, cannabis oils, and vaporizers for civilian patients and veterans; adult use recreational cannabis under the SHRED, Big Bag O' Buds, Monjour, SHRED'ems, Edison Cannabis Co, Edison JOLTS, Tremblant, and Laurentian brands; and cannabis edibles products and concentrates.